Background

Dr. Joel F. Martin, Ph.D. has been the Chief Executive Officer and President of Cebix Incorporated since October 2012. Dr. Martin also serves as the Chief Executive Officer of AnalgesiX Inc. He served as the Chief Executive Officer and President at Altair Therapeutics, Inc. He served as Partner and Key Voting Member of Forward Ventures V, L.P. He served as Partner of Forward Ventures IV, L.P. from 2001 to 2008 and served as Key voting Member. He was a Partner and Chief ... Executive Officer at Forward Ventures. He was responsible for all aspects of life-science venture capital, including investment decisions, and fund raising and also led investments in Hypnion, Predix, and Cellective Therapeutics. Dr. Martin co-founded Quantum Dot Corporation in 1998 and served as its President and Chief Executive Officer. He co-founded Argonaut Technologies Inc., and served as its President and Chief Executive Officer. He is an accomplished entrepreneur and venture capitalist. His venture capital experience includes work with Avalon Ventures and Institutional Venture Partners, where he also contributed to the formation and development of Pharmacopeia Sequana Therapeutics (now Celera Genomics and Idun Pharmaceuticals. He serves as a Director of Hypnion, Inc. Dr. Martin serves as a Director of Altair Therapeutics, Inc. He serves as an Advisory Board Member for the Samuel Zell and Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan and serves on the Board of Bay Area Biosciences Center. He serves on the advisory board of the UCSD department of chemistry. He served as a Director of Predix Pharmaceuticals Holdings Inc. since January 2005 and Gryphon Therapeutics, Inc. He served as a Member of the board of Directors of Quantum Dot Corporation and also of Predix Pharmaceuticals Inc., since January 25, 2005. He served as Board Member of Argonaut Technologies, Inc. He served as a Member of the early scientific team of ISIS Pharmaceuticals and was previously on the faculty of the medical school of the University of California, San Diego. He serves as Member of Dean's Advisory Council at The Rady School of Management at the University of California, San Diego. Dr. Martin holds a Ph.D. in Physical Chemistry from U.C. San Diego and a B.S. Chem. Degree with Honors and an M.B.A. from the University of Michigan, Ann Arbor.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.